---
$id: https://graph.org.ai/products/commodity/51202409
$type: Product
source: UNSPSC
code: "51202409"
title: "Infliximab"
class: "51202400"
classTitle: "Immunosupressant antibodies"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Infliximab

**UNSPSC Code**: 51202409
**Class**: [Immunosupressant antibodies](Immunosupressant antibodies.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoclonal antibody with the molecular formula C6428H9912N1694O1987S46, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) B72HH48FLU, more generally known as infliximab. European Medicines Agency schedules infliximab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02681MIG. The term INFLIXIMAB is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 12 no. 1 1998, list 39. Most nations, for tariff and trade purposes, schedule infliximab under HS 30021091 and SITC 54163. As of Q4 2014, INFLIXIMAB remains US FDA's Preferred Term for this commodity. Infliximab bears US NLM identifiers UMLS ID C0666743 and NCI Concept Code C1789. SMILES: none.

